Transforming digital health with Meta Llama 3 NIM 🦙🚀💻

Transforming Digital Health with Meta Llama 3 NIM

Discover how Meta Llama 3, an innovative large language model, is revolutionizing the healthcare and life sciences industries. Dive into the ways in which this technology is driving advancements in digital health workflows and improving patient outcomes across various applications.

Advancing Digital Biology

Techbio and pharmaceutical companies utilize Meta Llama 3 NIM for tasks related to generative biology, chemistry, and molecular prediction.
The model aids in building end-to-end workflows for drug discovery and clinical trials, providing valuable insights and predicting chemical properties.
Deloitte and Transcripta Bio are among the companies leveraging Llama 3 NIM for drug discovery and enhancing AI modeling suites for predicting drug effects at scale.

Bolstering Clinical Trials

Quantiphi and ConcertAI are leveraging Meta Llama 3 NIM to develop generative AI solutions for clinical research, diagnostics, and patient care.
ConcertAI integrates Llama 3 NIM into its CARA AI platform to improve patient-to-trial matching and study automation, enhancing clinical trial processes.
Mendel AI utilizes a fine-tuned version of the model for its Hypercube copilot, exploring new applications and improving performance in extracting clinical information.

Improving Digital Surgery

Activ Surgical uses Meta Llama 3 to advance its AI copilot and augmented reality solutions for real-time surgical guidance, aiming to reduce surgical complications.
The ActivSight technology provides critical physiological insights to surgeons during operations, enhancing surgical precision and outcomes.

Enhancing Digital Health

Meta Llama 3 is also enhancing patient-doctor interactions, with applications like SimBioSys analyzing breast cancer diagnoses and guiding physicians based on patient characteristics.
Artisight automates documentation and care coordination in clinical settings using Llama 3, streamlining healthcare processes.
AITEM and Abridge are leveraging Llama 3 for healthcare-specific chatbots and summarization solutions, improving clinical conversations and patient care.